Navigation Links
Stryker Announces Additional $500 Million Share Repurchase Program and Declares a 20% Increase in Quarterly Dividend
Date:12/8/2010

KALAMAZOO, Mich., Dec. 8, 2010 /PRNewswire-FirstCall/ -- Stryker Corporation (NYSE: SYK) announced today that its Board of Directors has increased its dividend by 20% by declaring a quarterly dividend of $0.18 per share payable on January 31, 2011, to shareholders of record at the close of business on December 31, 2010.  

Stryker also announced today that its Board of Directors has authorized the Company to repurchase an additional $500 million of its common stock.  The manner, timing and amount of any purchases will be determined by the Company's management based on their evaluation of market conditions, stock price and other factors and will be subject to regulatory considerations.  Purchases may be made from time to time in the open market, in privately negotiated transactions or otherwise.  

The strength of Stryker's balance sheet and considerable cash flow allow for the return of significant value to shareholders through both dividends and share repurchases while simultaneously making the necessary investments that will drive continued sales and earnings growth. Since the start of 2010, Stryker has returned approximately $238 million to shareholders through dividends. In addition, under the existing $750 million share repurchase program, the Company has repurchased approximately $410 million as of December 7, 2010, of which approximately $300 million was purchased since the beginning of the fourth quarter.

"Our strong performance in 2010 has allowed us to both meaningfully boost our R&D spending, while also continuing our pattern over the last few years of consistently and significantly increasing our dividend," said Stephen P. MacMillan, Chairman, President and Chief Executive Officer of Stryker. "The 20% dividend increase, coupled with the additional share repurchase authorization resulting from our strong cash flow generation, positions us well to continue to increase shareholder value."

Stryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care.  The Company provides innovative orthopaedic implants as well as state-of-the-art medical and surgical equipment to help people lead more active and more satisfying lives.  For more information about Stryker, please visit www.stryker.com.


'/>"/>
SOURCE Stryker Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus
2. Medtronic, Stryker, and BrainLAB Covered in New Surgical Navigation Market Research Reports Released by Millennium Research Group
3. Stryker Announces Acquisition of Privately-Held Porex Surgical
4. Boston Scientific Agrees to Sell Neurovascular Business to Stryker
5. Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010
6. Stryker to Host Conference Call on October 19, 2010
7. Stryker to Present at Investor Conference
8. Stryker to Host Conference Call on July 20, 2010
9. Stryker Declares a $0.15 Per Share Quarterly Dividend
10. Stryker Facilities Earn LEED® Certifications
11. Stryker Enters Strategic Marketing Agreement with Acuitec
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
Breaking Medicine News(10 mins):